Psychopathological disorders in Prader-Willi syndrome
- PMID: 31006652
- DOI: 10.1016/j.endinu.2019.03.004
Psychopathological disorders in Prader-Willi syndrome
Abstract
Prader-Willi syndrome is a genetic disorder caused by chromosomal changes in segment 15q11-q13 including cognitive, mental, and behavioral symptoms, as well as a specific physical phenotype. Both the most common psychopathological changes (intellectual disability, obsessions, impulsivity, autism spectrum disorders, self-injuries) and the main psychiatric comorbidities (affective disorders, psychosis, obsessive-compulsive disorder, autism spectrum disorder) are characterized by a great heterogeneity, which warrants the need for better identification of their frequency and clinical signs. In addition to its effects on body compositionand hypotony, growth hormone has been shown to be useful for regulating patient behavior, and psychoactive drugs are also an option. Other alternatives have shown promising results in experimental trials. Adequate understanding of the psychopathology associated to Prader-Willi syndrome would allow for improving clinical approach, symptom identification, detection of comorbidities, and administration of more effective treatments, leading to better clinical outcomes.
Keywords: Comorbidity; Comorbilidad; Prader-Willi syndrome; Psicopatología; Psychopathology; Síndrome de Prader-Willi.
Copyright © 2019 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.Pediatrics. 2006 Oct;118(4):e1276-83. doi: 10.1542/peds.2006-0424. Epub 2006 Sep 18. Pediatrics. 2006. PMID: 16982806 Free PMC article.
-
Behavioral characteristics of Prader-Willi syndrome in Korea: comparison with children with mental retardation and normal controls.J Child Neurol. 2005 Feb;20(2):134-8. doi: 10.1177/08830738050200021001. J Child Neurol. 2005. PMID: 15794180
-
Psychopharmacology of neurobehavioral disorders.Handb Clin Neurol. 2019;165:383-390. doi: 10.1016/B978-0-444-64012-3.00023-X. Handb Clin Neurol. 2019. PMID: 31727225 Review.
-
Cognitive and behavioral heterogeneity in genetic syndromes.J Pediatr (Rio J). 2014 Mar-Apr;90(2):155-60. doi: 10.1016/j.jped.2013.06.010. Epub 2013 Oct 30. J Pediatr (Rio J). 2014. PMID: 24184301
-
Psychiatric disorders in Prader-Willi syndrome: epidemiology and management.CNS Drugs. 2003;17(3):167-78. doi: 10.2165/00023210-200317030-00003. CNS Drugs. 2003. PMID: 12617696 Review.
Cited by
-
One Year of Recombinant Human Growth Hormone Treatment in Adults with Prader-Willi Syndrome Improves Body Composition, Motor Skills and Brain Functional Activity in the Cerebellum.J Clin Med. 2022 Mar 25;11(7):1831. doi: 10.3390/jcm11071831. J Clin Med. 2022. PMID: 35407437 Free PMC article.
-
Prader-Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach.Curr Obes Rep. 2022 Dec;11(4):263-276. doi: 10.1007/s13679-022-00478-w. Epub 2022 Sep 5. Curr Obes Rep. 2022. PMID: 36063285 Free PMC article. Review.
-
An Exploratory Analysis on the 2D:4D Digit Ratio and Its Relationship with Social Responsiveness in Adults with Prader-Willi Syndrome.J Clin Med. 2023 Feb 1;12(3):1155. doi: 10.3390/jcm12031155. J Clin Med. 2023. PMID: 36769803 Free PMC article.
-
Caring and living with Prader-Willi syndrome in Italy: integrating children, adults and parents' experiences through a multicentre narrative medicine research.BMJ Open. 2020 Aug 6;10(8):e036502. doi: 10.1136/bmjopen-2019-036502. BMJ Open. 2020. PMID: 32764084 Free PMC article.
-
Social Responsiveness and Psychosocial Functioning in Adults with Prader-Willi Syndrome.J Clin Med. 2022 Mar 5;11(5):1433. doi: 10.3390/jcm11051433. J Clin Med. 2022. PMID: 35268524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical